Mechanisms of immune evasion by head and neck cancer stem cells

Flávia Caló Aquino Xavier1, Jamerson Carvalho Silva1, Camila Oliveira Rodini2

  • 1Laboratory of Oral Surgical Pathology, School of Dentistry, Federal University of Bahia, Salvador, BA, Brazil.

Frontiers in Oral Health
|August 19, 2022
PubMed

Insights

Head and Neck Cancer Stem Cells (HNCSCs) evade immune surveillance through various mechanisms. Understanding these interactions is key to improving immunotherapies for head and neck cancers.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Stem Cell Biology

Background:

  • Oral and Head and Neck Cancer Stem Cells (HNCSCs) play a critical role in tumor immune evasion.
  • HNCSCs employ diverse mechanisms to suppress the immune response within the tumor microenvironment.

Purpose of the Study:

  • To review current knowledge on how HNCSCs contribute to immune evasion.
  • To highlight strategies for overcoming immune evasion driven by HNCSCs.

Main Methods:

  • Review of existing literature on HNCSCs and immune evasion mechanisms.
  • Analysis of cell surface receptors, secreted factors, cell-cell crosstalk, and genetic regulation.
  • Examination of specific markers and pathways involved in immune suppression.

Main Results:

  • HNCSCs reduce CD8+ T cell recruitment and impair anti-PD-1 therapy efficacy via BMI1 expression.
  • Natural Killer (NK) cell ligands and cytokines are crucial for controlling tumor growth and targeting CSCs.
  • ALDH1-expressing CSCs correlate with increased PD-L1 and DNMT3b expression, while CD276 acts as a checkpoint inhibitor, suppressing CD8+ T cells.

Conclusions:

  • Understanding the interplay between HNCSCs and immune cells is vital for head and neck cancer treatment.
  • Targeting HNCSC-mediated immune evasion can optimize treatment strategies and enhance responses to immunotherapy.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K